Stock Ticker

  • Loading stock data...

Advaxis, Inc. (NASDAQ:ADXS) Gets IND Acceptance From The Food And Drug Administration For ADXS-NEO

Advaxis, Inc. (NASDAQ:ADXS) has revealed that the Food and Drug Administration of the United States has given the go-ahead for an application filed to try out ADXS-NEO. Development of the treatment is being done in partnership with Amgen, Inc. (NASDAQ:AMGN). “The IND acceptance is a landmark step towards escaping the one-size-fits-all approach to cancer treatments […]

Advaxis, Inc. (NASDAQ:ADXS) Names Oncologist Samir Khleif To Its Board

Boston, MA 10/09/2014 (wallstreetpr) – Advaxis, Inc. (NASDAQ:ADXS) disclosed that it has named Oncologist and research scientist, Samir Khleif, to its Board of Directors. He has over two decades of experience in the field of oncology, immunotherapy and tumor immunology. Ideal Addition According to a statement issued to the media, the company said that Khleif’s […]

News Update: Ecosphere Technologies, Inc. (OTCQB:ESPH); CGI Group Inc. (USA) (NYSE:GIB); Advaxis, Inc. (NASDAQ:ADXS)

Boston, MA 10/09/2014 (wallstreetpr) – Manufacturing firm, Ecosphere Technologies, Inc. (OTCQB:ESPH), announced on 8th October that it has completed the manufacturing and handing over of a innovative water treatment system called Ozonix® EF10M to Brasil Clean Energy. Brasil Clean Energy is a company which has been championing the cause of clean and sustainable usage of […]

Advaxis, Inc. (NASDAQ:ADXS) To Start Trial Of Immune Therapies Against Prostate Cancer In Collaboration With Merck & Co., Inc. (NYSE:MRK)

Boston, MA 08/25/2014 (wallstreetpr) – Advaxis, Inc. (NASDAQ:ADXS) announced that it would be taking up testing of experimental immuno-oncology drugas prostate cancer treatment. Advaxis said that the drug shall be tested along with a much esteemed immunotherapy from Merck & Co., Inc. (NYSE:MRK). Testing the Use of ADXS-PSA Advaxis, Inc. is a small biotechnology company in […]

Sign Up To Get Our Latest Stocks Alerts